Pulmonary Infectious Diseases: Tuberculosis, Fungal Infections, and Post-COVID-19 Respiratory Sequelae

This chapter synthesizes recent advances in the diagnosis and management of major pulmonary infectious diseases, including drug-resistant tuberculosis, invasive fungal infections, and non-tuberculous mycobacterial disease, within the context of evolving global epidemiology and antimicrobial stewardship principles. Special attention is given to the pulmonary manifestations and long-term respiratory consequences of SARS-CoV-2 infection, incorporating the latest understanding of post-COVID-19 condition and its impact on lung structure and function.